Coronary artery disease and liver transplantation

Cardiovascular Diseases and Liver Transplantation

Volumn , Issue , 2011, Pages 31-48

  Findlay, James Y ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84864320679     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (79)

1. Johnston SD Morris JK Cramb R, Gunson BK, Neuberger J. Cardiovascular morbidity and mortality after orthotopic liver transplantation. Transplantation 2002; 73: 901-6.
2. Pruthi J, Medkiff KA, Esrason KT, Donovan JA, Yoshida EM, Erb SR et al. Analysis of causes of death in liver transplant recipients who survived more than 3 years. Liver Transpl 2001; 7: 811-5.
3. Fouad TR, Abdel-Razek WM, Burak KW, Bain VG, Lee SS. Prediction of cardiac complications after liver transplantation. Transplantation 2009; 87: 763-770.
4. Plotkin JS, Scott VL, Pinna A, Dobsch BP, De Wolf AM, Kang Y. Morbidity and mortality in patients with coronary artery disease undergoing orthotopic liver transplantation. Liver Transpl Surg 1996; 2: 426-30.
5. Plevak DJ. Stress echocardiography identifies coronary artery disease in liver transplant candidates. Liver Transpl. Surg 1998; 4: 337-9.
6. Diedrich DA, Findlay JY, Harrison BA, Rosen CB. Influence of coronary artery disease on outcomes after liver transplantation. Transplant. Proc 2008; 40: 3554-7.
7. Fraker TD, Jr., Fihn SD, Gibbons RJ, Abrams J, Chatterjee K, Daley J et al. 2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina. J Am Coll Cardio. 2007; 50: 2264-74.
8. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352: 1685-95.
9. Smith EJ, Jain AK, Rothman MT. New developments in coronary stent technology. J Interv Cardiol 2006;19: 493-9.
10. Howell WL, Manion WC. The low incidence of myocardial infarction in patients with portal cirrhosis of the liver: A review of 639 cases of cirrhosis of the liver from 17,731 autopsies. Am Heart J 1960; 60: 341-4.
11. Otsubo R, Higuchi Mde L, Gutierrez PS, Benvenuti LA, Massarollo PC, Costa AL, Ramires JA. Influence of chronic liver disease on coronary atherosclerosis vulnerability features. Int J Cardiol 2006; 109: 387-391.
12. Parrish HM, Eberly AL, Jr. Negative association of coronary atherosclerosis with liver cirrhosis and chronic alcoholism--a statistical fallacy. JJ Indiana State Med Assoc 1961; 54: 341-7.
13. Kalaitzakis E, Rosengren A, Skommevik T, Bjornsson E. Coronary artery disease in patients with liver cirrhosis. Dig Dis Sci 2010; 55: 467-75.
14. Carey WD, Dumot JA, Pimentel RR, Barnes DS, Hobbs RE, Henderson JM et al. The prevalence of coronary artery disease in liver transplant candidates over age 50. Transplantation 1995; 59: 859-64.
15. Tiukinhoy-Laing SD, Rossi JS, Bayram M, De Luca L, Gafoor S, Blei A et al. Cardiac hemodynamic and coronary angiographic characteristics of patients being evaluated for liver transplantation. Am J Cardio 2006; 98: 178-81.
16. Aydinalp A, Bal U, Atar I, Ertan C, Aktas A, Yildirir A et al. Value of stress myocardial perfusion scanning in diagnosis of severe coronary artery disease in liver transplantation candidates. Transplant Proc 2009; 41: 3757-60.
17. Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population 1986;111: 383-90.
18. Gordon T, Kannel WB, Hjortland MC, McNamara PM. Menopause and coronary heart disease. The Framingham Study. Ann Intern Med 1978; 89: 157-61.
19. Reuben A. Alcohol and the liver. Curr Opin Gastroenterol 2006; 22: 263-71.
20. Sofair AN, Barry V, Manos MM, Thomas A, Zaman A, Terrault NA et al. The Epidemiology and Clinical Characteristics of Patients With Newly Diagnosed Alcohol-related Liver Disease: Results From Population-based Surveillance. J Clin Gastroenterol 2010; 44: 301-7
21. Te HS, Jensen DM. Epidemiology of hepatitis B and C viruses: a global overview. Clin Liver Dis 2010; 14: 1-21
22. Donovan CL, Marcovitz PA, Punch JD, Bach DS, Brown KA, Lucey MR, Armstrong WF. Two-dimensional and dobutamine stress echocardiography in the preoperative assessment of patients with end-stage liver disease prior to orthotopic liver transplantation. Transplantation 1996; 61: 1180-8.
23. Findlay JY, Keegan MT, Pellikka PP, Rosen CB, Plevak DJ. Preoperative dobutamine stress echocardiography, intraoperative events, and intraoperative myocardial injury in liver transplantation. Transplant Proc 2005; 37: 2209-13.
24. Safadi A, Homsi M, Maskoun W, Lane KA, Singh I, Sawada SG, Mahenthiran J. Perioperative risk predictors of cardiac outcomes in patients undergoing liver transplantation surgery. Circulation 2009;120: 1189-94.
25. Tsutsui JM, Mukherjee S, Elhendy A, Xie F, Lyden ER, O'Leary E et al. Value of dobutamine stress myocardial contrast perfusion echocardiography in patients with advanced liver disease. Liver Transpl 2006;12: 592-9.
26. Umphrey LG, Hurst RT, Eleid MF, Lee KS, Reuss CS, Hentz JG et al. Preoperative dobutamine stress echocardiographic findings and subsequent short-term adverse cardiac events after orthotopic liver transplantation. Liver Transpl 2008;14: 886-92.
27. Arslan U, Turkoglu S, Balcioglu S, Tavil Y, Karakan T, Cengel A. Association between nonalcoholic fatty liver disease and coronary artery disease. Coron Artery Dis 2007;18: 433-6.
28. Assy N, Djibre A, Farah R, Grosovski M, Marmor A. Presence of coronary plaques in patients with nonalcoholic fatty liver disease. Radiology 2010; 254: 393-400.
29. Gronbaek M. Epidemiologic evidence for the cardioprotective effects associated with consumption of alcoholic beverages. Pathophysiology 2004;10: 83-92.
30. Corrao G, Rubbiati L, Bagnardi V, Zambon A, Poikolainen K. Alcohol and coronary heart disease: a meta-analysis. Addiction 2000; 95: 1505-23.
31. Plotkin JS, Benitez RM, Kuo PC, Njoku MJ, Ridge LA, Lim JW et al. Dobutamine stress echocardiography for preoperative cardiac risk stratification in patients undergoing orthotopic liver transplantation. Liver Transpl Surg 1998;4(4):253-7.
32. Henriksen JH, Moller S. Cardiac and systemic haemodynamic complications of liver cirrhosis. Scand Cardiovasc J 2009; 43: 218-25.
33. Rabie RN, Cazzaniga M, Salerno F, Wong F. The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt. Am J Gastroenterol 2009;104: 2458-66.
34. Reich DL, Wood RK, Jr., Emre S, Bodian CA, Hossain S, Krol M, Feierman D. Association of intraoperative hypotension and pulmonary hypertension with adverse outcomes after orthotopic liver transplantation. J Cardiothorac Vasc Anesth 2003;17: 699-702.
35. Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999;100: 1043-49.
36. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof EL, Fleischmann KE et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Col. Cardiol 2007; 50): e159-241.
37. Poldermans D, Bax JJ, Boersma E, De Hert S, Eeckhout E, Fowkes G et al. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). Eur. Heart J 2009;30: 2769-2812.
38. Eagle KA, Berger PB, Calkins H, Chaitman BR, Ewy GA, Fleischmann KE et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 2002; 39: 542-53.
39. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof EL, Fleischmann KE et al. ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coll Cardio. 2007; 50: 1707-32.
40. Dharancy S, Lemyze M, Boleslawski E, Neviere R, Declerck N, Canva V et al. Impact of impaired aerobic capacity on liver transplant candidates. Transplantation 2008; 86: 1077-83.
41. Iscar M, Montoliu MA, Ortega T, Rodriguez B, Rodriguez M, Glez-Pinto I, Alonso P. Functional capacity before and after liver transplantation. Transplant Proc 2009; 41: 1014-5.
42. Mori T, Nomura M, Hori A, Kondo N, Bando S, Ito S. Mechanism of ST segment depression during exercise tests in patients with liver cirrhosis. J Med Invest 2007; 54: 109-115.
43. Beattie WS, Abdelnaem E, Wijeysundera DN, Buckley DN. A meta-analytic comparison of preoperative stress echocardiography and nuclear scintigraphy imaging. Anesth. Analg. 2006;102: 8-16.
44. Harinstein ME, Flaherty JD, Ansari AH, Robin J, Davidson CJ, Rossi JS et al. Predictive value of dobutamine stress echocardiography for coronary artery disease detection in liver transplant candidates. Am J Transplant 2008;8: 1523-28.
45. Williams K, Lewis JF, Davis G, Geiser EA. Dobutamine stress echocardiography in patients undergoing liver transplantation evaluation. Transplantation 2000;69: 2354-6.
46. Wong F, Girgrah N, Graba J, Allidina Y, Liu P, Blendis L. The cardiac response to exercise in cirrhosis. Gut 2001;49: 268-75.
47. Davidson CJ, Gheorghiade M, Flaherty JD, Elliot MD, Reddy SP, Wang NC et al. Predictive value of stress myocardial perfusion imaging in liver transplant candidates. Am J Cardiol.2002;89: 359-60.
48. Zoghbi GJ, Patel AD, Ershadi RE, Heo J, Bynon JS, Iskandrian AE. Usefulness of preoperative stress perfusion imaging in predicting prognosis after liver transplantation. Am J Cardiol 2003;92: 1066-71.
49. Kryzhanovski VA, Beller GA. Usefulness of preoperative noninvasive radionuclide testing for detecting coronary artery disease in candidates for liver transplantation. Am J Cardiol 1997;79: 986-8.
50. Das MK, Pellikka PA, Mahoney DW, Roger VL, Oh JK, McCully RB, Seward JB. Assessment of cardiac risk before nonvascular surgery: dobutamine stress echocardiography in 530 patients. J Am Coll Cardiol 2000;35: 1647-53.
51. Morgan PB, Panomitros GE, Nelson AC, Smith DF, Solanki DR, Zornow MH. Low utility of dobutamine stress echocardiograms in the preoperative evaluation of patients scheduled for noncardiac surgery. Anesth. Analg. 2002; 95: 512-16.
52. Nagel E, Lehmkuhl HB, Bocksch W, Klein C, Vogel U, Frantz E et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation 1999; 99: 763-70.
53. Sharma M, Yong C, Majure D, Zellner C, Roberts JP, Bass NM et al. Safety of cardiac catheterization in patients with end-stage liver disease awaiting liver transplantation. Am J Cardiol 2009;103: 742-6.
54. Kumar N, Dahri L, Brown W, Duncan N, Singh S, Baker C et al. Effect of elective coronary angiography on glomerular filtration rate in patients with advanced chronic kidney disease. Clin J Am Soc Nephrol 2009; 4: 1907-13.
55. Schuijf JD, Pundziute G, Jukema JW, Lamb HJ, van der Hoeven BL, de Roos A et al. Diagnostic accuracy of 64-slice multislice computed tomography in the noninvasive evaluation of significant coronary artery disease. Am J Cardiol 2006; 98: 145-8.
56. Buffa V, De Cecco CN, Cossu L, Fedeli S, Vallone A, Ruopoli R et al. Preoperative coronary risk assessment with dual-source CT in patients undergoing noncoronary cardiac surgery. Radiol. Med 2010; 115: 1028-37
57. Pletcher MJ, Tice JA, Pignone M, Browner WS. Using the coronary artery calcium score to predict coronary heart disease events: a systematic review and meta-analysis. Arch Intern Med 2004; 164: 1285-92.
58. McAvoy NC, Kochar N, McKillop G, Newby DE, Hayes PC. Prevalence of coronary artery calcification in patients undergoing assessment for orthotopic liver transplantation. Liver Transpl 2008;14: 1725-31.
59. Hickson LJ, Cosio FG, El-Zoghby ZM, Gloor JM, Kremers WK, Stegall MD et al. Survival of patients on the kidney transplant wait list: relationship to cardiac troponin T. Am J Transplant 2008; 8: 2352-9.
60. Hickson LT, El-Zoghby ZM, Lorenz EC, Stegall MD, Jaffe AS, Cosio FG. Patient survival after kidney transplantation: relationship to pretransplant cardiac troponin T levels. Am J Transplant 2009; 9: 1354-61.
61. Bittar J, Arenas P, Chiurchiu C, de la Fuente J, de Arteaga J, Douthat W, Massari PU. Renal transplantation in high cardiovascular risk patients. Transplant. Rev. (Orlando). 2009; 23: 224-34.
62. Stel VS, van Dijk PC, van Manen JG, Dekker FW, Ansell D, Conte F et al. Prevalence of co-morbidity in different European RRT populations and its effect on access to renal transplantation. Nephrol Dial Transplant 2005; 20: 2803-11.
63. Patel RK, Mark PB, Johnston N, McGeoch R, Lindsay M, Kingsmore DB et al. Prognostic value of cardiovascular screening in potential renal transplant recipients: a single-center prospective observational study. Am. J Transplant 2008; 8: 1673-83.
64. Eagle KA, Rihal CS, Mickel MC, Holmes DR, Foster ED, Gersh BJ. Cardiac risk of noncardiac surgery: influence of coronary disease and type of surgery in 3368 operations. CASS Investigators and University of Michigan Heart Care Program. Coronary Artery Surgery Study. Circulation 1997; 96(6): 1882-7.
65. Hassan SA, Hlatky MA, Boothroyd DB, Winston C, Mark DB, Brooks MM, Eagle KA. Outcomes of noncardiac surgery after coronary bypass surgery or coronary angioplasty in the Bypass Angioplasty Revascularization Investigation (BARI). Am. J Med. 2001;110: 260-6.
66. McFalls EO, Ward HB, Moritz TE, Goldman S, Krupski WC, Littooy F et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 2004;351: 2795-2804.
67. Poldermans D, Schouten O, Vidakovic R, Bax JJ, Thomson IR, Hoeks SE et al. A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V Pilot Study. J Am. Coll Cardiol 2007;49: 1763-9.
68. Filsoufi F, Salzberg SP, Rahmanian PB, Schiano TD, Elsiesy H, Squire A, Adams DH. Early and late outcome of cardiac surgery in patients with liver cirrhosis. Liver Transpl 2007;13: 990-5.
69. Axelrod D, Koffron A, Dewolf A, Baker A, Fryer J, Baker T et al. Safety and efficacy of combined orthotopic liver transplantation and coronary artery bypass grafting. Liver Transp. 2004;10: 1386-90.
70. Grines CL, Bonow RO, Casey DE, Jr., Gardner TJ, Lockhart PB, Moliterno DJ et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. J Am Coll Cardiol 2007;49: 734-39.
71. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293: 2126-30.
72. Nuttall GA, Brown MJ, Stombaugh JW, Michon PB, Hathaway MF, Lindeen KC et al. Time and cardiac risk of surgery after bare-metal stent percutaneous coronary intervention. Anesthesiology 2008;109: 588-95.
73. Rabbitts JA, Nuttall GA, Brown MJ, Hanson AC, Oliver WC, Holmes DR, Rihal CS. Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents. Anesthesiology 2008;109: 596-604.
74. Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008;371: 1839-47.
75. Lindenauer PK, Pekow P, Wang K, Mamidi DK, Gutierrez B, Benjamin EM. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med. 2005; 353: 349-61.
76. Fleischmann KE, Beckman JA, Buller CE, Calkins H, Fleisher LA, Freeman WK et al. 2009 ACCF/AHA focused update on perioperative beta blockade: a report of the American college of cardiology foundation/American heart association task force on practice guidelines. Circulation 2009;120: 2123-51.
77. Miller LW. Cardiovascular toxicities of immunosuppressive agents. Am. J Transplant 2002;2: 807-18.
78. Smith SC, Jr., Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol 2006;47: 2130-9.
79. Mells G, Neuberger J. Reducing the risks of cardiovascular disease in liver allograft recipients. Transplantation 2007;83: 1141-50.